Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

CJC-1295: Contraindications & Drug Interactions

Safety information for CJC-1295 including known contraindications, drug interactions, and important precautions.

Back to CJC-1295 overview

Contraindications

  • active malignancy
  • untreated pituitary disorders

Drug Interactions (2 interactions)

Important: This table summarizes known and theoretical interactions. Always consult a healthcare provider before combining CJC-1295 with any medication.
Drug Classification Mechanism
glucocorticoids Documented May blunt GH response
insulin Theoretical GH release may alter insulin sensitivity

Use our interactive Drug Interaction Checker for real-time lookup.